ITRACONAZOLE
- Product NDC
- 70518-3264
- 11-digit product format
- 705183264
- Labeler code
- 70518
- Product ID
- 70518-3264_d07442a5-7d29-cc25-e053-2a95a90aecb5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- itraconazole
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA206741
- Marketing category
- ANDA
- Marketing start
- 2021-11-08
- Marketing end
- 0000-00-00
- Substance
- ITRACONAZOLE
- Active strength
- 100 mg/1
- Pharmacologic classes
- Azole Antifungal [EPC],Azoles [CS],Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-3264-0 | 70518326400 | 14 CAPSULE in 1 BOTTLE, PLASTIC (70518-3264-0) | 14 capsule | 2021-11-08 | 0000-00-00 | No | No | Current |